CRISPR Therapeutics AG (CRSP)
50.04
-0.03
(-0.06%)
USD |
NASDAQ |
Nov 09, 16:00
50.82
+0.78
(+1.56%)
After-Hours: 18:26
CRISPR Therapeutics Gross Profit (Annual) : -229.45M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -229.45M |
| December 31, 2024 | -92.20M |
| December 31, 2023 | 221.12M |
| December 31, 2022 | -133.22M |
| December 31, 2021 | 897.01M |
| December 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| December 31, 2014 | -0.038M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 10.27B |
| Basilea Pharmaceutica AG | 232.46M |
| Santhera Pharmaceuticals Holding AG | 17.42M |
| BeOne Medicines Ltd. | 4.569B |
| Intellia Therapeutics, Inc. | 51.75M |